Correlation Between Lipella Pharmaceuticals and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipella Pharmaceuticals Common and SAB Biotherapeutics, you can compare the effects of market volatilities on Lipella Pharmaceuticals and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and SAB Biotherapeutics.
Diversification Opportunities for Lipella Pharmaceuticals and SAB Biotherapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lipella and SAB is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Lipella Pharmaceuticals and SAB Biotherapeutics
Given the investment horizon of 90 days Lipella Pharmaceuticals is expected to generate 13.39 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Lipella Pharmaceuticals Common is 3.96 times less risky than SAB Biotherapeutics. It trades about 0.03 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 4.04 in SAB Biotherapeutics on August 27, 2024 and sell it today you would earn a total of 3.26 from holding SAB Biotherapeutics or generate 80.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 76.8% |
| Values | Daily Returns |
Lipella Pharmaceuticals Common vs. SAB Biotherapeutics
Performance |
| Timeline |
| Lipella Pharmaceuticals |
| SAB Biotherapeutics |
Lipella Pharmaceuticals and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipella Pharmaceuticals and SAB Biotherapeutics
The main advantage of trading using opposite Lipella Pharmaceuticals and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |